Thus, in our model, the possibility exists that the TSf-ISPA formulation generates a better control of the infection by modulating the immune response in a way that increases components of a Th1 response, increases the absolute number of specific CD4+Foxp3+ Treg cells with protective capacity, and decreases the generalized immunosuppression induced by MDSC cells. Here, FOXP3 is linked to infection.